Chambers Research is conducted by 200 Research Analysts, across 200 jurisdictions and provides nearly 6,000 rankings tables. Annually we collect hundreds of thousands of responses from clients, the majority via in-depth interview. Learn more about our methodology.
Market-leading Japan-based IP team, also enjoying a sound reputation in this space across Mainland China and Hong Kong and extending to Singapore. Especially strong in patent litigation cases, and in handling cross-border transactional matters. Possesses an impressive client following among technology, pharmaceutical and biotechnology companies. Also advises on the IP issues arising out of data privacy, cybersecurity regulations and related compliance questions.
An interviewee highlights the team's "substantive knowledge of legal issues, combined with its practical and commercial approach to advising clients."
"Dealing with Morrison & Foerster has been a wonderful experience," reports a source.
Advised Taisho Pharmaceutical on the purchase of trade mark and other intellectual property as part of its USD1.6 billion acquisition of UPSA from Bristol Myers Squibb.
Gordon Milner and Sun Chuan co-head the firm's China IP practice and are main contacts in the Hong Kong office. Max Olson is a key point of contact in the Tokyo office.